Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
11/2001
11/01/2001US20010036945 Certain Isoquinolinamine and phthalazinamine derivatives; corticotropin-releasing factor receptor CRF1 specific ligands
11/01/2001CA2407663A1 Inhibitors of dipeptidyl peptidase iv
10/2001
10/31/2001EP1149079A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
10/31/2001EP0929543B1 Herbicidal composition
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/30/2001US6310208 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines
10/25/2001WO2001079173A2 Enamine derivatives as cell adhesion molecules
10/25/2001WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001WO2001025238A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
10/25/2001WO2001019798A3 Inhibitors of factor xa
10/25/2001US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/24/2001EP1148050A1 Retroviral protease inhibitors
10/24/2001EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/23/2001US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/18/2001US20010031870 Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protese inhibitors
10/18/2001US20010031765 Antiviral compounds
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001CN1318059A Isoquinolines as urokinase inhibitors
10/17/2001CN1073080C Process for mfg. mixed anhydrides
10/16/2001US6303786 Salt formation in a solvent
10/16/2001US6303785 Substituted n-cyclopropyltetrahydroisoquinolines
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074808A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides
10/11/2001WO2001074782A1 β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
10/11/2001WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
10/11/2001WO2000050376A9 Efficient synthesis of alkyl carbonates
10/11/2001DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate
10/11/2001CA2405126A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides
10/11/2001CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001CA2393788A1 .beta.3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
10/10/2001EP1142878A2 Pharmaceutical compositions comprising moexipril magnesium
10/10/2001EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001EP1140853A1 Continuous process for the preparation of optically pure decahydroisoquinolinecarboxamide
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1139744A1 Exo-r-mecamylamine formulation and use in treatment
10/10/2001EP1139743A1 Exo-s-mecamylamine formulation and use in treatment
10/10/2001EP0839135B1 Process for preparing optically active 1-(p-methoxybenzyl)-1,2,3,4,5,6,7,8-octahydroisoquinoline
10/09/2001US6300342 Antithrombotic phenylalkyl derivatives
10/09/2001US6300341 2-substituted heterocyclic sulfonamides
10/09/2001CA2082825C Inhibition of viral infection
10/05/2001CA2303481A1 Pharmaceutical compositions comprising moexipril magnesium
10/04/2001WO2001072712A1 ISOQUINOLONE INHIBITORS OF FACTOR Xa
10/04/2001US20010027200 PPARgamma modulators
10/04/2001EP1137647A1 Thiourea inhibitors of herpes viruses
10/04/2001EP1137645A2 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
10/04/2001EP1137638A2 Isoquinoline derivatives
10/04/2001EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
10/04/2001EP1137632A1 Thiourea inhibitors of herpes viruses
09/2001
09/27/2001WO2001070731A1 Decahydro-isoquinolines
09/27/2001WO2001070684A2 Peptidomimetic ligands for cellular receptors and ion channels
09/27/2001WO2001070269A1 Keratinocyte growth inhibitors and hydroxamic acid derivatives
09/27/2001US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives
09/27/2001US20010025045 Substituted isoquinoline derivatives and their use as anticonvulsants
09/27/2001US20010025044 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
09/26/2001EP0900214B1 Process for preparation of pyrimidine derivatives
09/25/2001US6294551 N-linked sulfonamides of heterocyclic thioesters
09/25/2001US6294504 Antidotes for herbicides
09/20/2001WO2001068609A1 1,2,3,4-tetrahydroisoquinoline derivatives
09/20/2001WO2001068591A1 Carboxylic acid derivatives as ip antagonists
09/20/2001WO2001068585A1 Novel amide compounds
09/20/2001WO2000047553A8 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
09/19/2001CN1313286A S type 4-substituted hydroxypyranoindolidine compound and its derivatives and preparation thereof
09/18/2001US6291677 Compounds having activity as inhibitors of cytochrome P450RAI
09/18/2001US6289892 Partial liquid breathing of fluorocarbons
09/13/2001US20010021782 Production of amide derivatives and intermediates therefor
09/12/2001EP0794945B1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof
09/11/2001US6288123 Therapeutic guanidines
09/07/2001WO2001064648A1 Isoquinoline derivatives
09/07/2001WO2001064647A1 Isoquinoline derivatives as pde4 inhibitors
09/07/2001WO2001064643A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
09/07/2001WO2001064642A2 Benzamides and related inhibitors of factor xa
09/06/2001US20010020021 Metalloprotease inhibitor
09/06/2001US20010020013 Polymerase inhibitors
09/05/2001EP1129076A1 Tetrahydroisoquinoline derivatives as lhrh antagonists
09/05/2001CN1311773A Neuropeptide Y5 receptor antagonists
09/04/2001US6284796 Naphthamidine compounds
09/04/2001US6284735 HP-3228 and related peptides to treat sexual dysfunction
08/2001
08/30/2001WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
08/30/2001WO2000071510A3 INHIBITORS OF FACTOR Xa
08/30/2001US20010018538 Silylating the corresponding carbamate compound; alkylation
08/30/2001US20010018451 Raloxifene, tamoxifen
08/30/2001US20010018423 Anticoagulant agents
08/29/2001EP1127884A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
08/29/2001EP1126839A1 Substituted phenethylsulfones and method of reducing tnf alpha levels
08/29/2001CN1310709A N.N-substituted cyclic amine derivatives
08/29/2001CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
08/29/2001CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use
08/29/2001CN1070173C Benzoylaguanidine derivatives using as medicine
08/28/2001US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/23/2001WO2001060798A1 Amine derivatives for the treatment of apoptosis
08/23/2001WO2000071508A3 Inhibitors of factor Xa
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 119